Pharm Flashcards
Ondansetron (zofran)
Anti-emetic - acute
MOA: bind serotonin receptors in GI tract
Tox: Headache, hiccups, QT long, constipation
Aprepitant (Emend)
Anti-emetic - delayed
MOA: NK1 receptor antagonist (central and peripheral action)
Tox: drug interaction, hiccups, fatigue
Prochlorperazine (compazine)
Anti-emetic - delayed
MOA: bind dopamine D1/D2 receptors in chemoreceptor trigger zone
Tox: extrapyramidal side effects, sedation
Dexamethasone (Decadron)
corticosteroid used for anti-emetic properties
MOA: unknown
Tox: glucose intolerance, insomnia, agitation
Lorazepam (Ativan)
benzo used for anit-emetic properties
MOA: limbic, thalamic and hypothalamic areas via GABA
Tox: sedation, retrograde amnesia
Metoclorpramide (Reglan)
Anti-emetic
MOA: bind dopamine D1/D2 receptors in chemoreceptor trigger zone
Tox: extrapyramidal side effects, sedation
Epoetin alfa
short acting RBC growth factor
- must have adequate iron stores
Tox: hypertension, rash, arthralgias
Darbepoetin
long acting RBC growth factor
- must have adequate iron stores
Filgrastim
G-CSF - myeloid growth factor for neutropenia
Tox: fever (cytokines), bone pain (marrow elements), increase in uric acid, LDH, alk phos, rash
Pegfilgrastim
G-CSF - myeloid growth factor for neutropenia
- also has PEG to double weight (decreases clearance)
Tox: fever (cytokines), bone pain (marrow elements), increase in uric acid, LDH, alk phos, rash
Alkylating agents toxicity
- Bone marrow suppression
- nausea, vomiting diarrhea, anorexia
- sterility
- amenorrhea
- 2nd malignancy
MOA of platinum compounds
binds to DNA, RNA and produces covalent crosslinks
resistance mechanisms
- increase glutathione-S-transferase
- augmented DNA repair
- altered cellular transport
- altered DNA repair mechanism
Cisplatin
Platinum alkylating agent
- highly emetogenic (use zofran and dexamethasone)
- nephrotoxic
- neurotoxic
Cisplatin nephrotoxicity
inactivation of renal brush border (rf = high plasma levels, kidney damage, hypoalbumin, female, other drugs)
- acute - decrease electrolyte, increase BUN
- chronic - reduced GFR, normal creatinine
- anemia
Prevention - hydration, hypertonic saline, mannitol (osmotic diuretic), infusions
cisplatin neurotoxicity
- axonal degeneration
- peripheral neuropathy (stocking glove, cumulative doses)
- auditory impairment
- visual disturbances
oxaliplatin
Platinum alkylating agent
- sensory neuropathy in cold
- infusion reaction
carboplatin
Platinum alkylating agent
- hypersensitivity
- nausea vomiting
- neurotoxicity
- taxane?
- no nephrotoxicity
cyclophosphamide
Nitrogen mustard alkylator
MOA: binds to nucleophiles, DNA crosslinking, inactivation of template
Extra: removed by dialysis, is a prodrug activiated in lived
cyclophosphamide toxicity
- N/V
- myelosuppressive
- cardionecrosis
ifosfamide
nitrogen mustard alkylator
- requires hepatic P450 for activation
- produces acrolein
acrolein
metabolite of cyclophosphamide and ifosfamide
urotoxic
ifosfamide toxicity
neurotoxicity
hemorrhagic cystitis
neutropenia
nephrotoxicity - ATN
treated with methylene blue
mensa
binds acrolein in the bladder, requires multiple doses
prednisone
glucocorticoid
- immunsuppressive effects
- lympholytic
flutamide
anti androgen receptor
Tox: hot flashes, gynecomastia and breast tenderness
bicalutamide
anti androgen receptor
Tox: hot flashes, gynecomastia and breast tenderness
tamoxifen
anti estrogen binder, cell cycle specific
stimulates TGF-beta which inhibits TGF alpha and IGF-1 leading to decreased proliferation
raloxifene
anti estrogen binder, cell cycle specific
stimulates TGF-beta which inhibits TGF alpha and IGF-1 leading to decreased proliferation
letrozole
aromatase inhibitor - blocks conversion of androgen to estrogen, no effects of
cotricosteroid
Tox: arthralgias, ms pain, hot flashes, LFT
anastrozole
aromatase inhibitor - blocks conversion of androgen to estrogen, no effects of corticosteriod
Tox: astheia, hot flashes, peripheral edema, arthralgias
exemestane
aromatase inhibitor - blocks conversion of androgen to estrogen, no effects of corticosteriod
Tox: hot flashes, fatigue, headache
leuprolide
LH-RH agonist - suppression of gonadotropin, results in LH/FSH decrease
Usually has short term disease flare due to short term surge
goserelin
LH-RH agonist - suppression of gonadotropin, results in LH/FSH decrease
Usually has short term disease flare due to short term surge
methotrexate
binds reversibly to DHF reductase, S phase specific - leads to no purine synthesis
methotrexate pharmokinetics
- binds to albumin = drug interactions
- can accumulate in effusions
- high doses can cross to CNS
most important type of methotrexate metabolism
polyglutamation by enzyme FPGS
leucovorin
stable form of reduced folate, used for rescue of healthy cells
timing is very important should be continued until MTX is less than .05uM
methotrexate toxicity
- renal toxicity (need to hydrate/alkalyze urine)
- GI toxicity
- effusions
Rare
- hepatotoxicity
- derm
- myelosuppression
- others
methotrexate drug interactions
- albumin binding
- nephrotoxic drugs
- can be helped with L-asparaginase
cytarabine
Chain elongation terminator
only available as an infusion, can cross BBB, can distribute into tears
cytarabine toxicity
normal
- myelosuppression
- flu like
- mucositis
- hand and foot
high
- cerebellar tox
- ocular tox - tearing
- pulmonary edema
5-Fluorouracil
false pyrimidine that inhibits formation of thymidine, effects augmented by leucovorin
5-Fluorouracil pharmacokinetis
metabolized by DPD (many polymorphisms)
can be used in pts with hepatics and renal dysfunction
5-Fluorouracil toxicity
- myelosuppresion
- mucositis/diarrhea
- hand/foot
- neurotox
- chest pain, EKG
- photosensitivity
gemcitabine
similar to cytarabine, can incorporate in RNA, metabolized by cytidine deaminase (in urine)
gemcitabine tox
- myelosuppression
- flu
- flushing/headache
gemcitabine interactions
radiosensitizer, enhances cytotoxicity of cisplatin
anthracyclines MOA
passive diffusion, nucleated cells, intercalate DNA, Topo 2 inhibitor, form reactive compounds, oxygen radicals, uses iron 3+, important in cardiotox
anthracyclines Tox
- myelosuppression
- alopecia
- N/V
- extravasation
- *cardiotoxicity acute and chronic (EKG changes vs LVEF chagnes)
dexrazoxane
chelating agent used to prevent cardiotoxicity in anthracycline use, EDTA analog, binds to iron
doxorubicin
anthracyclines
daunorubicin
anthracyclines
liposomal anthracycline
made to reduce cardiotoxicity, slows release of the drug
irinotecan
topo 1 inhibitor, given by IV
irinotecan side effects
neutropenia, thrombocytopenia, eosinophilia
- diarrhea (early cholinergic - late watery diarrhea)
- N/V
- rare pneumonitis
irinotecan resistance
p-glycoprotein - reduced drug accumulation
- altered intracellular drug distribution
- variability in drug metabolism
- differences in Topo 1 expression/mutation
vinca alkaloids MOA
disturb microtuble formation, prevent formation of mitotic spindle
vinca alkaloids tox
vincristine - neurotoxicity (peripheral neuropathy)
- decrease autonomic
- NOT bone marrow
vinblastine - myelosuppression
vinblastine
vinca alkaloid - bone marrow problems
vincristine
vinca alkaloid - neurotoxicity problems
vesicant
vinorelbine
vinca alkaloid - same toxicity as other vinca alkaloid
paclitaxel
M phase - enhances microtubule polymerization
- resistance in MDR, alterations in tubules
tox: myelosuppression, meuropathy, infusion reaction
docetaxel
M phase - enhances microtubule polymerization
- resistance in MDR, alterations in tubules
tox: myelosuppression, meuropathy, infusion reaction
rituximab
anti-CD20, used in non-hodgkin lymphoma and RA
rituximab
immunosuppressive, infusion related, tumor lysis, HAMA/HACA
cetuximab
binds to EGFR
tox: infusion related, rash, asthenia, N/V, hepato
trastuzumab
anti HER2/neu monoclonal
Tox: infusion related, pain, myelosuppresion, cardiotox`
bevacizumab
anti VEGF preventing angiogenesis
Tox: imparied wound healing, hemorrhage, hypertension, trombotic events, bleeding
ecluzimab
anti-complement (C5) used to treat PNH
imatinib
small molecule inhibitor of BRC-ABL tyrosine kinase
Tox: edema, cytopenias, LFT, cardiotoxicity
erlotinib
EGFR inhibitor
MOA of imids
antiangiogensis
- basic fibroblast growth factor and VEGF
- immunomodulatory
- induces apoptosis
drugs that cause delayed nausea and vomiting
Cyclophosphamide, cisplatinum, and doxorubicin
unfractionated hepartin
requires AT-III, augments its, neutralizes thrombin, 10, 9 and 11a
argatroban
direct thrombin inhibitors used in HIT
enoxaparin
LMWH inhibits factor Xa more than 2 (thrombin) - leads to less bleeding
dalteparin
LMWH
Fondaparinux
synthetic low molecular weight heparin
protamine
used to reverse heparin, cant be used with fondazparinux
Idarucizamab
reversal agent of direct thrombin inhibitors
Lepirudin
direct thrombin inhibitor, no AT3 necessary
Dabigatran
direct thrombin inhibitor - no ATIII necessary
Rivaroxaban
direct factor Xa inhibitor
Clopidogrel
ADP receptor antagonist
Prasugrel
ADP receptor antagonist
abciximab
GPIIb/IIIa blockers – IV
tetratogenic antithromin med
warfarin